Clade Therapeutics Funding: $87M Raised, Series A (2021)
Clade Therapeutics is based in Cambridge, MA. It has raised $87M in total funding. Latest round: Series A.
Clade Therapeutics funding overview
Clade Therapeutics is based in Cambridge, MA. Clade Therapeutics has raised $87M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in August 2021. The round record for Clade Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Syncona, LifeSci Venture Partners, Emerson Collective, Bristol Myers Squibb. 4 distinct backers are named across the disclosed rounds.
Clade Therapeutics has raised $87M in total disclosed funding across the rounds on record.
Who has invested in Clade Therapeutics?
Syncona, LifeSci Venture Partners, Emerson Collective, Bristol Myers Squibb are named among the investors backing Clade Therapeutics.
What was the latest Clade Therapeutics funding round?
The most recent disclosed round is a Series A, announced in August 2021.
Where is Clade Therapeutics based?
Clade Therapeutics is based in Cambridge, MA.
When did Clade Therapeutics last raise?
The last disclosed Clade Therapeutics round closed in August 2021 at Series A.
Clade Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.
